Skip to main content

Table 2 Proportions of “HDM-only” patients using the indicated medications during each questionnaire period (2013)

From: The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries

 

2013

Early Jan.

Late Jan.

Early Feb.

Late Feb.

Early Mar.

Late Mar.

Early Apr.

Late Apr.

Early May

Late May

Early June

Late June

Early July

Antihistamines

42%

37%

38%

37%

38%

44%

46%

39%

43%

39%

32%

33%

42%

Nasal corticoids

12%

17%

18%

18%

17%

13%

16%

13%

10%

14%

15%

13%

6%

Inhaled corticoids

3%

2%

2%

2%

2%

2%

2%

1%

2%

1%

2%

3%

Bronchodilators

4%

7%

5%

6%

8%

2%

4%

5%

8%

7%

5%

3%

Inhaled corticoid + bronchodilator

4%

5%

6%

4%

2%

7%

2%

3%

5%

6%

6%

5%

3%

Other corticoids

4%

5%

2%

2%

5%

3%

5%

1%

3%

4%

Eye drops

4%

5%

2%

8%

6%

3%

5%

5%

9%

6%

6%

7%

6%

Leukotriene receptor antagonist

3%

5%

5%

2%

6%

3%

5%

5%

5%

5%

4%

4%

6%

Nasal decongestants

7%

13%

6%

8%

4%

7%

5%

8%

6%

5%

8%

5%

9%

Other anti-H1

1%

2%

2%

2%

1%

1%

Other nasal sprays

3%

2%

2%

2%

3%

5%

1%

4%

6%

Cromone

Cough syrups

2%

3%

Pain killers

3%

2%

3%

4%

2%

3%

4%

3%

5%

3%

7%

3%

Antimigraine drugs

1%

1%

Homeopathy

1%

2%

Antibiotics

2%

Other

8%

5%

16%

8%

12%

18%

13%

9%

7%

9%

7%

14%

15%